)
Willem Koenders
Head of Commercialization,
INBRAIN
Willem Koenders is a seasoned MedTech executive with 17 years of experience in Medtronic’s Neuromodulation division, where he held commercial leadership roles across Europe. He recently joined Inbrain Neuroelectronics as Head of Commercialization, leading the go-to-market strategy for groundbreaking brain-computer interface (BCI) therapies.
At Inbrain, Willem is helping drive the company’s mission to decode brain signals to improve the lives of patients living with neurological disorders. The company leverages graphene-based neurotechnology to develop new generation of BCI therapies that are minimally invasive, high resolution, and personalized. INBRAIN got FDA breakthrough designation for their innovative neural platform and delivered the world's first application of a graphene-based neural interface in humans.
At Inbrain, Willem is helping drive the company’s mission to decode brain signals to improve the lives of patients living with neurological disorders. The company leverages graphene-based neurotechnology to develop new generation of BCI therapies that are minimally invasive, high resolution, and personalized. INBRAIN got FDA breakthrough designation for their innovative neural platform and delivered the world's first application of a graphene-based neural interface in humans.
Sessions
-
11-Jun-2025Tech Horizons StageBrain Computer Interfaces: Enhancing the Human Potential